Abstract:A series of new chelating bidentate (SS) alkylimidazole-2-thione-Ru(II)/Os(II) complexes (3ai, 3aii, 3aiii, 3bii/4aiii, 4bi, 4bii), and the tridentate (SNS) pyridine-2,6-diylimidazole-2-thione-Ru(II)/Os(II) complexes (5bi, 5civ/6bi, 6ci, 6civ) in the forms [MII(cym)(L)Cl]PF6 and [MII(cym)(L)]PF6 (M = Ru or Os, cym = η6-p-cymene, and L = heterocyclic derivatives of thiourea) respectively, were successfully synthesized. Spectroscopic and analytical methods were used to characterize the complexes and their ligands. Solid-state single-crystal X-ray diffraction analyses revealed a "piano-stool" geometry around the Ru(II) or Os(II) centers in the respective complexes. The complexes were investigated for in vitro chemotherapeutic activities against human cervical carcinoma (HeLa) and the non-cancerous cell line (Hek293) using the MTT assay. The compounds 3aii, 5civ, 5bi, 4aiii, 6ci, 6civ, and the reference drug, 5-fluorouracil were found to be selective toward the tumor cells; the compounds 3ai, 3aiii, 3bii, 4bi, 4bii, and 6bi, which were found not to be selective between normal and tumor cell lines. The IC50 value of the tridentate half-sandwich complex 5bi (86 ± 9 μM) showed comparable anti-proliferative activity with the referenced commercial anti-cancer drug, 5-fluorouracil (87 ± 15 μM). The pincer (SNS) osmium complexes 6ci (36 ± 10 μM) and 6civ (40 ± 4 μM) were twice as effective as the reference drug 5-fluorouracil at the respective dose concentrations. However, the analogous pincer (SNS) ruthenium complex 5civ was ineffective and did not show anti-proliferative activity, even at a higher concentration of 147 ± 1 μM. These findings imply that the higher stability of the chelating (SS) and the pincer (SNS) ligand architectures in the complexes improves the biological (anti-proliferative) activity of the complexes by reducing the chance of ligand dissociation under physiological conditions. In general, the pincer (SNS) osmium complexes were found to be more cytotoxic than their ruthenium analogues, suggesting that the anti-proliferative activity of the imidazole-2-thione-Ru/Os complexes depends on the ligand's spatial coordination, the nature of the metal center, and the charge of the metal complex ions.

New Dinuclear Ruthenium Arene Complexes Containing Thiosemicarbazone Ligands: Synthesis, Structure and Cytotoxic Studies.

Synthesis, characterization, and cytotoxicity of new types of binuclear platinum(II) complexes

Synthesis, Cytotoxicity and Anti‐metastatic Properties of New Pyridyl–thiazole Arene Ruthenium(ii) Complexes

Dinuclear arene ruthenium(II) arylthiourea complexes: Synthesis, structure, cancer cell growth inhibition and apoptosis induction studies

Synthesis, characterization, and anticancer activity of dithiocarbamate ruthenium(II) complexes

Dissymmetric Thiosemicarbazone Ligands Containing Substituted Aldehyde Arm and Their Ruthenium(Ii) Carbonyl Complexes with Pph3/Asph3 As Ancillary Ligands: Synthesis, Structural Characterization, Dna/Bsa Interaction and in Vitro Anticancer Activity

Synthesis and Biological Activity of Binuclear Platinum Complexes Containing Two Monofunctional Cis-[Pt(Nh3)(2)Cl](+) Units Bridged by 4,4 '-Dipyridyl Selenides or Sulfides

Palladium(II) Complexes with N,N′-Dialkyl-1,10-phenanthroline-2,9-dimathanamine: Synthesis, Characterization and Cytotoxic Activity

Dna Binding And Photocleavage Properties, Cellular Uptake And Localization, And In-Vitro Cytotoxicity Of Dinuclear Ruthenium(Ii) Complexes With Varying Lengths In Bridging Alkyl Linkers

Toward a New Avenue in Ruthenium-Sulphur Chemistry of Binuclear Μ -Sulphido Bridged ( Μ -S) 2 Complexes Having Ru 2 S 2 Core: Targeted Synthesis, Crystal Structure, Biomolecules Interaction and Their in Vitro Anticancer Activities

THE SYNTHESIS AND CHARACTERIZATION OF DINUCLEAR PLATINUM COMPLEXES BRIDGED BY DIPYRIDYL SELENIDES OR SULFIDES

Synthesis, DNA-binding, molecular docking and cytotoxic activity in vitro evaluation of ruthenium(II) complexes

Unprecedented Formation Of Organo-Ruthenium(Ii) Complexes Containing 2-Hydroxy-1-Naphthaldehyde S-Benzyldithiocarbazate: Synthesis, X-Ray Crystal Structure, Dft Study And Their Biological Activities In Vitro

Syntheses, Characterization and Antitumor Activity of Three Mononuclear Ruthenium(II) Complexes

Synthesis and Antitumor Activity of Dinuclear Platinum Complexes with (1(i)R, 1(ii)R, 2(i)R, 2(ii)R)-N-i,N-ii-(1, 3-Phenylenebis(methylene))dicyclohexane-1, 2-diamie as the Ligand

Novel thiosemicarbazone complexes as anticancer agents: Synthesis, characterization, cytotoxicity, docking, and density functional theory studies

Half-Sandwich Arene Ruthenium(II) Thiosemicarbazone Complexes: Evaluation of Anticancer Effect on Primary and Metastatic Ovarian Cancer Cell Lines

Synthesis, Cytotoxicity and DNA-binding Levels of New Type Binuclear Platinum(ii) Complexes

Chemotherapeutic Activities of New η6-p-Cymene Ruthenium(II) and Osmium(II) Complexes with Chelating SS and Tridentate SNS Ligands

Rhodium(I) Complexes Containing the N^N^N-Chelating Ligand: Synthesis, Structure, and Biological Activity

Binuclear Monofunctional Platinum(ii) Complexes Formed by Hexaazamacrocyclic Bisdien Ligands: Crystal Structure, DNA Binding and Cytotoxicity Studies